Immunomodulatory therapy of cutaneous T-cell lymphoma: A multimodality approach in advanced disease - 24/08/11
Doi : 10.1016/j.jaad.2009.09.024
Jacqueline M. Junkins-Hopkins, MD ⁎ 
Based on the dialogue “Therapy of advanced cutaneous T-cell lymphoma” between Alain H. Rook, MD, and Jacqueline M. Junkins-Hopkins, MD
Division of Dermatopathology and Oral Pathology, Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, Maryland
Reprint requests: Jacqueline M. Junkins-Hopkins, MD, Division of Dermatopathology and Oral Pathology, Department of Dermatology, Johns Hopkins Medical Institution, 601 N Wolfe St, Blalock 9, Baltimore, MD 21287.Abstract |
Dialogues in Dermatology, a monthly audio program from the American Academy of Dermatology, contains discussions between dermatologists on timely topics. Commentaries from Dialogues Editor-in-Chief Jacqueline M. Junkins-Hopkins, MD, are provided after each discussion as a topic summary and are provided here as a special service to readers of the Journal of the American Academy of Dermatology.
Le texte complet de cet article est disponible en PDF.| The statements and opinions expressed in this commentary are those of the Editor-in-Chief of Dialogues in Dermatology. |
|
| Funding sources: None. |
|
| Dislcosure: Dr Rook is a consultant to Merck and a speaker for Therakos. Dr Junkins-Hopkins declared no conflict of interest. |
© 2009
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 61 - N° 6
P. 1056-1058 - décembre 2009 Retour au numéro
Article précédent
- Treatment of psoriasis in patients with hepatitis C: From the Medical Board of the National Psoriasis Foundation
- Amylynne J. Frankel, Abby S. Van Voorhees, Sylvia Hsu, Neil J. Korman, Mark G. Lebwohl, Bruce F. Bebo, Alice B. Gottlieb, National Psoriasis Foundation
- Correction
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?